Purdue Opposes Requests To Delay Ch. 11 Plan For Appeals

By Vince Sullivan · October 25, 2021, 4:46 PM EDT

Purdue Pharma LP is arguing that delaying the consummation of its Chapter 11 plan to allow appeals to be resolved first would needlessly delay the distribution of billions of dollars for...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Response

Case Information

Case Title

Purdue Pharma L.P.

Case Number

Court

New York Southern

Nature of Suit

Date Filed

September 15, 2019

Recent Articles By Vince

June 10, 2024
Ventilator Co. Vyaire Hits Ch. 11 As COVID Demand Wanes
May 17, 2024
Healthcare Co. Sues Steward In Ch. 11 Over Military Contract
March 12, 2024
Breast Implant Co.'s $90M DIP OK'd With Creditor Protections
March 04, 2024
Hospital Operator Pushes For Ch. 11 Plan Confirmation
February 06, 2024
Cano Health DIP Gets Initial OK Without $23M Lender Fees
January 22, 2024
Skin Care Drug Co. Timber Gets OK For Ch. 11 Sale To Lender
January 10, 2024
US Trustee Calls SmileDirect Ch. 11 Deal An Improper Plan
December 06, 2023
GenesisCare Gets OK For $20M DIP Funding Hike
December 01, 2023
Alecto Health Can Continue With Subchapter V Designation
November 29, 2023
Alecto Health Co. Says Threshold Met For Subchapter V Status